What is Cogent Biosciences, Inc.'s net investment in lease?

Cogent Biosciences, Inc. (COGT) reported net investment in lease of $17.55M in Q1 2026.

How has Cogent Biosciences, Inc.'s net investment in lease changed year-over-year?

Cogent Biosciences, Inc.'s net investment in lease decreased by 10.5% year-over-year, from $19.6M to $17.55M.

What is the long-term trend for Cogent Biosciences, Inc.'s net investment in lease?

Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s net investment in lease has grown at a 31.4% compound annual growth rate (CAGR), from $4.62M to $18.08M.

Cogent Biosciences, Inc. COGT Net Investment in Lease

Net Investment in Lease at other companies

Tango TherapeuticsTNGX

——

CG OncologyCGON

——

Scholar RockSRRK

——

CRISPR TherapeuticsCRSP

——

BridgeBio PharmaBBIO

——

Roivant SciencesROIV

——

Other financials

Income statement

See full

Operating income-$103.6M-38.3%

Net income-$97.4M-35.2%

EPS (diluted)-$0.53-1.9%

Balance sheet

See full

Cash & equivalents$241.2M+91.4%

Total debt$15.5M-9.4%

Total equity$607.7M+177%

Total assets$903.0M+218%

Cash flow

See full

Operating cash flow-$86.9M-30.6%

CapEx$449.0K-17.9%

Free cash flow-$87.3M-30.2%

Valuation

See full

Market cap$5.9B+816%

Enterprise value$5.68B+951%

P/S749.8×—

Profitability

See full

Operating margin-1,044.3%—

Net margin-950.4%—

FCF margin-184.7%—

Returns & leverage

See full

Return on equity-85.7%+1.7pp

Debt / equity0×-0.1×

Current ratio15.1×+10.0×

Where this comes from

Reported directly by Cogent Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cogent Biosciences, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cogent Biosciences, Inc.'s net investment in lease?: Cogent Biosciences, Inc. (COGT) reported net investment in lease of $17.55M in Q1 2026.
How has Cogent Biosciences, Inc.'s net investment in lease changed year-over-year?: Cogent Biosciences, Inc.'s net investment in lease decreased by 10.5% year-over-year, from $19.6M to $17.55M.
What is the long-term trend for Cogent Biosciences, Inc.'s net investment in lease?: Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s net investment in lease has grown at a 31.4% compound annual growth rate (CAGR), from $4.62M to $18.08M.